Mrs Emily Reed Butler, RN, BSN, IBCLC | |
1500 Royce Rd, Homewood, AL 35209-1728 | |
(205) 587-7422 | |
Not Available |
Full Name | Mrs Emily Reed Butler |
---|---|
Gender | Female |
Speciality | Registered Nurse - Lactation Consultant |
Location | 1500 Royce Rd, Homewood, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609524305 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WL0100X | Registered Nurse - Lactation Consultant | 1-119447 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Emily Reed Butler, RN, BSN, IBCLC 1500 Royce Rd, Homewood, AL 35209-1728 Ph: (205) 587-7422 | Mrs Emily Reed Butler, RN, BSN, IBCLC 1500 Royce Rd, Homewood, AL 35209-1728 Ph: (205) 587-7422 |
News Archive
About 80% of stroke survivors experience hemiparesis, which causes weakness or the inability to move one side of the body. Core stabilization exercise to improve postural stability and independent walking in chronic hemiparetic stroke patients could be enhanced by real-time video feedback, report researchers in Restorative Neurology and Neuroscience.
GlucoMen are delighted to announce the launch of an innovative new way for people with diabetes to manage their condition better, with the new GlucoMen Areo blood glucose meter.
Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.
Researchers have used artificial intelligence to reduce the 'communication gap' for nonverbal people with motor disabilities who rely on computers to converse with others.
Celldex Therapeutics, Inc. today announced that the Company presented initial clinical data on CDX-1401 at the 25th Annual Meeting of the International Society of Biological Therapy of Cancer (iSBTc) in Washington, DC. CDX-1401 is a novel antibody-based targeted cancer vaccine candidate being evaluated as a treatment for patients with melanoma and other cancers that are known to express the tumor antigen NY-ESO-1.
› Verified 4 days ago
Mathleen Craig, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1625 Lakeshore Ct Apt B, Homewood, AL 35209 Phone: 205-209-1157 | |
Ryan Frederick Ernst, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 306 Devon Dr, Homewood, AL 35209 Phone: 205-907-5599 | |
Annalin Elise Wren, FNP-C Registered Nurse Medicare: Medicare Enrolled Practice Location: 3125 Independence Dr Ste 200, Homewood, AL 35209 Phone: 205-930-0920 Fax: 205-445-0115 | |
Megan Morris, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2006 Brookwood Medical Ctr Dr, Homewood, AL 35209 Phone: 205-566-6175 | |
Jacquelyn Salceiro, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 232 Raleigh Ave, Homewood, AL 35209 Phone: 904-554-3645 | |
Mrs. Cecily Metzler, NP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2006 Brookwood Medical Ctr Dr Ste 302, Homewood, AL 35209 Phone: 205-315-6951 Fax: 866-829-2082 | |
Ms. Gara Maxine Johnson, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 234 Goodwin Crest Dr, Homewood, AL 35209 Phone: 205-290-4599 Fax: 205-290-4560 |